Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Blog
Quality Control in Clinical, Interview with Sharon Riley
Image
Workers' Comp
Blog
Opioid Risk Mitigation: Medication-Assisted Treatment (MAT) and Naloxone
This week in our in-dept
Workers' Comp
News Release
Risk & Insurance: 10 Workers' Comp Podcasts You Really Don't Want to Miss
When it comes to learning about the workers' compensation industry, there is a plethora of resources already at your fingertips.
Mitchell
Article
The Black Lives Matter Movement Is Changing Us for the Better
The first half of 2020 has been unprecedented. There has been some good, a lot of bad and even some ugly.
Mitchell
News Release
Mitchell Announces Cloud-Based Glass Claims and Repair Management Solution
San Diego, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Blog
Jurisdictional Rules and Opioid Impacts in 2019
With a continued focus on the harmful effects of the opioid epidemic, oversight of opioid prescribing and monitoring of use t